drugset / Trial / NCT00629889

Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors

NCT00629889

Phase 2 Completed 52 enrolled Dr Andrea Rossetti
RandomizedParallel-groupOpen-labelSupportive care

Summary

RATIONALE: Levetiracetam and pregabalin are drugs that treat seizures. It is not yet known which drug is more effective in treating seizures caused by primary brain tumors. PURPOSE: This randomized phase II trial is studying the side effects and how well levetiracetam or pregabalin work in treating seizures in patients undergoing chemotherapy and/or radiation therapy for primary brain tumors.

Timeline

Start
2008-02
Primary completion
2012-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levetiracetam Other / unclassified 1500 mg
Comparator Pregabalin Small molecule 300 mg